Advertisement
News
Advertisement

Ensemble inks $186M deal with Boehringer Ingelheim

Fri, 11/02/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Ensemble Therapeutics secured its fourth research collaboration with a big-name pharmaceutical company since the company was founded, all to develop drug candidates based on a type of molecule it hopes will bridge the divide between large- and small-molecule drugs.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading